Study on MCT Oil and Fatty Liver

Организация < < мед > >ium-chA/данные отсутствуют.В случае необходимости triglycerides (1. Политика 11(1)1)1)1)1. Политика 11)1. Политика 11)1)1)С. О.CTs) A/данные отсутствуют.re triglycerides дляmed По запросу: : категория: : категория: : категория: В настоящее время esterificA/данные отсутствуют.tiПо состоянию на Соединенные Штаты америки - толстый. - кислота- либо: : категория: : категория: : категория: : категория:s с carbon chaВ случае необходимости lengths Соединенные Штаты америки 6 По адресу: 10 carbon atoms и glycerol. They are primarily found В случае необходимости cocoa butter и palm 1. Нефть. I. Я. Я. Я. Яn the 1950s, MCT was first В случае необходимостиtroduced as a highly absorbable и energy-dense nutrient для the treatment Соединенные Штаты америки patients с impaired absorption Соединенные Штаты америки long-chaВ случае необходимости - толстый. - кислота;s [1]. Currently, MCT is widely used as one Соединенные Штаты америки the maВ случае необходимости components В случае необходимости enteral и parenteral nutrition support для the treatment Соединенные Штаты америки conditions such as biliary fibrosis, hyper- липид.emia, epilepsy, diarrhea, и fat malabsorption [2]. Compared to long-chaВ случае необходимости triglycerides, medium-chain triglycerides are hydrolyzed into medium-chain fatty acids, which have smaller 10. Молекулярная структура weights и higher water solubility. They can be directly absorbed by intestinal villi сout needing to be resynthesized into triglycerides, instead entering the bloodstream directly и traveling to the - печень. via the portal vein [3].

In - печень. 2. Камеры, medium-chain triglycerides can enter the mitochondria сout relying on carnitine-lipoyl carnitine transferase I (CPT-1) on the outer mitochondrial membrane, passing through the two layers Соединенные Штаты америки the mitochondrial membrane to enter the mitochondrial interior. There, they undergo fatty acid β-oxidation to produce acetyl CoA, or enter the tricarboxylic acid cycle и electron transport chain to generate ATP for energy, or form ketone bodies released into the bloodstream, for use by extra- печень. tissues. Организация < < мед > >ium-chain fatty acids provide rapid energy, reducing the demи for blood Глюкоза (глюкоза) и are less likely to accumulate in adipose tissue. Therefore, current research indicates that medium-chain fatty acids can control weight gain by increasing energy expenditure and suppressing appetite [4].

However, medium-chain fatty acids are not essential fatty acids, so dietary intake should be supplemented with essential long-chain unsaturated fatty acids. 1. Оipids in the body primarily include triglycerides, non-esterified fatty acids, total cholesterol, non-HDL cholesterol, HDL cholesterol, phospho- липид.s, etc. Medium-chain triglycerides, as a - тип Соединенные Штаты америки saturated fatty acid, have a different metabolic Путь к успеху in the body compared to general long-chain fatty acids. However, their intake and breakdown also influence lipid synthesis and breakdown in the body, thereby affecting lipid Обмен веществ, particularly in plasma and liver tissues.

Literature reports indicate that MCT intake increases plasma triglyceride levels and LDL cholesterol concentrations [5,6]. Mice with long-chain acyl-CoA dehydrogenase deficiency, unable to utilize long-chain fatty acids for energy oxidation, exhibited plasma free fatty acid levels four times higher than wild-- тип mice after prolonged consumption of an MCT-В которых содержатся diet [7]. However, other studies have demonstrated that medium-chain triglycerides have no Воздействие на окружающую среду on plasma triglyceride levels, or that MCTs can even reduce plasma triglyceride levels and improve LDL and total cholesterol levels [1,8].

To avoid potential adverse effects of MCT diets on lipid profiles, a Исследования по теме: : категория: : категория: : категория: used flaxseed oil containing MCT, plant sterols, and η-3 fatty acids [6]. Human trials found that this flaxseed oil reduced LDL cholesterol in obese men and women but had no effect on triglycerides or HDL cholesterol [7]. A Исследования по теме: using MCFA and mustard oil fatty acids to construct structural lipids for the treatment of hypercholesterolemic rats found that it had a good improving effect on plasma and liver lipid Обмен веществ [9]. The following sections will discuss the therapeutic and application research progress of MCT according to different По борьбе с заболеваниями - типs.

I. MCT and Atherosclerosis

In recent years, improvements in living standards and changes in lifestyle have led to a steady increase in the incidence and mortality rates of Сердечно-сосудистые заболевания По борьбе с заболеваниямиs. The primary risk Факторы, влияющие на include obesity, diabetes, hypertension, elevated plasma cholesterol levels, and increased oxidative stress [10]. High concentrations of plasma LDL cholesterol and its oxidative modifications are the primary risk factors for the development of atherosclerosis [11].

Population and animal studies have shown that supplementation with the antioxidant α-tocopherol can reduce the extent of LDL oxidation. E. E.pidemiological surveys indicate that high intake of α-tocopherol is negatively associated with the incidence of heart По борьбе с заболеваниями in women [12]. Additionally, reducing the content of easily oxidizable polyunsaturated fatty acids in LDL cholesterol components can also decrease the occurrence of LDL oxidative modification [13]. Polyunsaturated fatty acids can lower plasma cholesterol [14], but they are substrates for lipid peroxidation reactions, and their intake increases the likelihood of LDL oxidation and the body's demand for antioxidants.

Although MCTs do not directly participate in the biochemical synthesis of LDL, they can also prevent atherosclerosis [15]. Oils rich in MCTs can reduce plasma free cholesterol levels by converting free cholesterol in plasma into cholesterol esters, thereby lowering total plasma cholesterol levels. Additionally, in the liver, MCFAs can be converted into acetyl CoA through fatty acid β-oxidation to synthesize cholesterol. The number of acetyl CoA molecules produced by MCFAs is far smaller than that of long-chain fatty acids, thereby reducing cholesterol synthesis. Therefore, MCFAs, like LCFAs, can also lower total cholesterol levels in the liver.

II. MCT and Alcoholic Liver Damage

The mechanism by which ethanol induces alcoholic liver injury may involve the production of large amounts of NADH by ethanol under the action of alcohol dehydrogenase and aldehyde dehydrogenase, which 3. Ингибиты NAD+-dependent tricarboxylic acid cycle and fatty acid β-oxidation processes, thereby increasing free fatty acid concentrations in the liver [16]. The reduced synthesis of microsomal triglyceride transfer Содержание белка в крови, which is responsible for transporting triglycerides В период между biological membranes and lipoСодержание белка в кровиs, leads to - печень. steatosis [17]. In the development and occurrence of alcohol-induced liver damage (ALD), unsaturated fatty acids play an important role, while saturated fatty acids can help prevent and treat alcoholic liver По борьбе с заболеваниямиs [18]. Existing evidence suggests that a diet containing saturated fatty acids with MCT can prevent В экспериментальном порядкеly induced alcoholic fatty liver, but the molecular mechanisms remain highly controversial.

Numerous experimental studies have shown that the mechanisms by which MCT oil reduces fatty liver lesions primarily include: : категория: : категория: : категория: : категория: : категория: : категория: : категория: : категория: : категория: : категория: ① Increased intake of dietary saturated fatty acids reduces the concentration of triglycerides, polyunsaturated fatty acids, and total free fatty acids in the liver, while MCT does not accumulate in the liver, thereby improving hepatic lipid Обмен веществ; ② increasing dietary saturated fatty acid intake reduces the concentration of unsaturated fatty acids in liver cell membranes, thereby reducing lipid peroxidation. Studies have found that the MCT oil group demonstrated superior tissue repair capacity in rats with alcoholic liver disease compared to the vitamin E intake group. However, when comparing the extent of reduced lipid peroxidation levels, there was no significant difference В период между the two groups, suggesting that MCT's regulatory effects are not solely mediated by reducing lipid peroxidation levels to improve tissue pathological damage. Changes in the synthesis of pro-Подстрекательство к насилию eicosanoids induced by dietary lipids are also important. Furthermore, improvements in alcoholic fatty liver disease are associated with reduced fatty acid synthesis, enhanced ω-oxidation of fatty acids catalyzed by CYP4A1, and increased lipid output [19].

Corn oil in the diet contains polyunsaturated fatty acids. When administered orally with ethanol, it can establish an animal model of alcoholic fatty liver disease. Feeding alcohol-induced liver disease rats with a diet partially replaced with MCT in place of corn oil revealed that as the content of saturated fatty acids increased, the indicators of liver lesions and oxidative stress progressively decreased, including reversible changes in hepatic steatosis [10].

III. MCT and Glycogen Storage Disease Type 1a

Glycogen storage disease - тип 1a is primarily caused by a deficiency of Глюкоза (глюкоза)-6-phosphatase, leading to carbohydrate metabolism disorders. It is often accompanied by severe hypoglycemia, hyperlactatemia, and hypertriglyceridemia. Patients with GSD1a - тип can prevent hypoglycemia and reduce blood lactate levels by following a high-carbohydrate, low-fat diet (such as cornstarch) in dietary therapy; however, there was no significant improvement in plasma triglyceride levels [20].

This is consistent with previous studies, which reported that elevated levels of acetyl-CoA in GSD1 patients inhibit the activity of carnitine palmitoyltransferase 1 (CPT-1), leading to the development of complications. MCT oxidation does not depend on CPT-1 activity. Studies have shown that after MCT intake, GSD1 patients did not exhibit clinical or biochemical adverse reactions, and it had positive effects on metabolic control and growth and development. MCT milk has been used to treat children with severe hypertriglyceridemia, and studies have found that it can significantly reduce triglyceride levels and is equally effective for patients with fatty acid oxidation disorders.

After administering MCT milk to a 13-year-old boy with GSD1a and two infants aged 6 months and 7 months, lipid metabolism (reduced blood triglyceride levels, increased HDL cholesterol and plasma ketone levels) and carbohydrate metabolism (blood glucose levels returned to normal, and significantly decreased lactate levels) were significantly improved. The results suggest that the inclusion of MCT milk in the diet may have a better preventive effect on the adverse effects of fat restriction on growth and development in infants with GSD1a.

IV. MCT and Long-Chain Acyl Coenzyme A Dehydrogenase Deficiency

Mitochondrial fatty acid β-oxidation is an important process that provides energy for a series of metabolic reactions. Long-chain acyl CoA dehydrogenase is the key enzyme for long-chain fatty acids to enter mitochondria for fatty acid β-oxidation. Its deficiency leads to fatty acid oxidation disorders, the most common of which is VLCAD deficiency.

Patients with VLCAD deficiency cannot oxidize fatty acids derived Из российской федерации diet or endogenous lipolysis, resulting in the accumulation of long-chain acyl CoA and acyl carnitine. Medium-chain triglycerides can generate acylcarnitine without the action of carnitine acylcarnitine transferase 1 (CPT-1), directly entering the mitochondrial cell membrane to undergo complete fatty acid β-oxidation for energy production, making it the dietary therapy of choice for VLCAD. Studies have found that VLCAD knockout mice fed an MCT diet for 5 weeks developed severe hepatic steatosis and lipid metabolism disorders.

Among these, the expression of lipid metabolism-related genes SREBP 1C, FASN, ACC-1α, and SCD1 was up-regulated, suggesting that fatty acid biosynthesis exceeded MCT degradation; and their liver triglyceride levels and serum free fatty acid levels were significantly higher than those on an LCT diet. This may be due to long-term MCT diet-induced changes in plasma lipid profiles; however, additional MCT intake did not affect liver or serum lipid levels. This may be related to the experimental dosage, as the MCT ratio in this study (MCT/Total fat = 4.4%/0.5%) exceeded the recommended daily dose for asymptomatic VLCAD newborns (LCT: MCT = 50:50). MCT, as a saturated fatty acid, is clinically applied to the treatment of obesity, diabetes, and other metabolic disorders. However, whether long-term intake may lead to corresponding metabolic disorders requires further investigation.

V. Outlook

The advantages of medium-chain triglycerides over long-chain triglycerides suggest that they can be synthesized into structural lipids through physical mixing or chemical methods and added to Продукты питания и напитки such as milk, cookies, and bread, or directly added to edible oils. This ensures the basic nutritional requirements for essential fatty acids while reducing the intake of long-chain fatty acids. If they can replace part of long-chain triglycerides for lipid metabolism disorders and obesity, they will undoubtedly gain widespread application. However, some studies have shown that long-term consumption of MCTs may induce lipid metabolism disorders. In future studies, the specific intake dosage and duration of consumption on the body's glucose and lipid metabolism will remain a key focus of research to maximize its benefits.

Ссылка на сайт

[1]Son - - - - J....S,Kim KC,Kim BK,et al.Effect of small hairpin РНК (RNA) targeting endothelin -converting enzyme-1 in monocrotaline-induced Легочные железы и легкие hypertensive rats[J].J Корейская народно-демократическая республика Med Sci,2012 ,27 ( 12) : 1507 -1516

[2]Zhang ZH,Lu Y,Luan Y,et al.Effect of bone marrow mesenchymal stem cells on experimental Легочные железы и легкие arterial hypertension[J].Exp Ther Med,2012,4(5) : 839-843

[3]Shih HJ,Chen HH,Chen YA,et и al.Targeting MCT-1 oncogene inhibits Shc pathway  and xenograft tumorigenicity [J].Oncotarget, 2012,3 ( 11) : 1401 -1415

[4] Geng Shanshan, Cai Donglian, Qu Dan, et al. Study on the effects of medium-chain triglyceride diet on neuropeptide Y and leptin [J]. Health Research, 2009, 38 (5): 538-541.

[5]Westin JR,Kurzrock R.It's about time : lessons for solid tumors from Хроническая токсичность - миелогенный Лейкемия (лейкемия) therapy[J].Моль (Mol) - Рак; Ther,2012 11 ( 12) : 2549-2555

[6]Zainol S,Basri M,Basri HB,et al.Formulation optimization of a palmbased nanoemulsion В системе организации объединенных наций containing levodopa[J].Int J Mol Sci, 2012,13 ( 10. Организация Объединенных Наций : 13049 -13064

[7]Ghoshal B,Sarkar N,Bhattacharjee М, и al.Glycogen storage disease 1a with piebaldism[J].Indian Pediatr,2012,49(3) : 235-236

[8]Kasapkara CS ,Tümer L ,Okur I ,et al.Hypercalcemia in glycogen storage disease type I patients of Turkish origin[J].Turk J Pediatr, 2012,54( 1) : 35-37

[9]Sara T,Sonja P,Frank TV,et al.Spiekerkoetter medium -chain triglycerides impair metabolism and induce hepatic steatosis in very longchain acyl -CoA dehydrogenase ( VLCAD) -deficient mice[J].Mole Gen Metab,2010,101 ( 1) :40-47

[10]Avery SM,Mahua G.Hypolipidemic effect of mustard oil enriched with medium chain fatty acid and polyunsaturaed fatty acid[J].Nutrition, 2011,27 ( 11) : 1183 -1193

[11]Sakellariou S,Al-Hussaini H,Scalori A,et al.Hepatocellular adenoma in glycogen storage disorder type I : a clinicopathological and molecular study [J].Histopathology,2012,60(6B) : E58 -E65

[12]Avogaro A.Towards evidence-based medicine : large-scale intervention trials with dipeptidyl peptidase-4 inhibitors[J].G Ital Cardiol,2012,13 ( 12) : 23-31

[13]Patsenker E,Stoll M ,Millonig G,et и al.Cannabinoid 3. Рецептор type I 2. Модуляты alcohol-induced liver fibrosis[J].Mol Med,2011 ; 17 ( 1112) : 1285 -1294

[14]Supakul R,Liangpunsakul S.Alcoholic -induced hepatic steatosisrole of ceramide and protein phosphatase 2A[J].Transl  Res, 2011,158 (2) :77-81

[15]Fajardo V,Varela-Moreiras G.Efficacy of adding folic acid to foods [J].Int J Vitam Nutr Res,2012 ,82(3) : 177 -186

[16]Au WY ,Chan SC.Association between glucose 6 -phosphate dehydrogenase ( G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men[J].Singapore Med J,2012 ,53 (2 ) : 148149

[17]Newman JC,He W,Verdin E.Mitochondrial protein acylation and intermediary metabolism : Правила и положения by sirtuins and implications for metabolic disease[J].J 1. Биол Chem,2012,287 (51) :42436 -42443

[18]Zarkesh M,Faam B,Daneshpour MS,et al.The relationship between metabolic syndrome ,cardiometabolic risk factors  and inflammatory 3. Маркеры in a Tehranian population : the Tehran lipid and glucose study [J].Intern Med,2012,51 (24) : 3329-3335

[19]Karaki C,Kasahara M,Sakamoto S,et al.Glycemic management in living donor liver transplantation for patients with glycogen storage disease type 1b[J].Pediatr Transplant,2012,16(5) :465-470

[20]Bandsma RH,Smith GP,Kuipers F.Disturbed lipid metabolism in glycogen storage disease type I[J].Eur J Pediatr,2002,161 ( 1) : 65-69